Publications
Patents & Papers
Our patent portfolio and key academic publications protecting and advancing RudaCure's core technology and research achievements.
10
Patent Families
35
Total Filings
4
Granted
11
Countries
7
Total Papers
Patent Portfolio
Securing global intellectual property rights for core ion channel drug discovery technologies.
Pharmaceutical Composition Containing 8-oxo-2'-deoxyguanosine for Treating Corneal Disease
Inventors: 정명희, 김동현
Eye Drop Formulations in Aqueous Solution Comprising 8-oxo-2'-deoxyguanosine
Inventors: 김동현, 박설규, 이동진, 김선경
2'-Deoxyguanosine Derivatives or Salts Thereof and Pharmaceutical Compositions
Inventors: 김용호, 김승훈, 구영아, 김완훈
Pharmaceutical Composition for Treating TRPV1-Mediated Diseases (GDF11 Active Ingredient)
Inventors: 김용호, 김승훈, 전하원, 하유승
A Novel Peptide and the Use Thereof
Inventors: 김용호, 김승훈, 전하원, 장예원
Composition for Pain Treatment
Inventors: 김승훈, 김윤연, 김재승, 최승혁
8-oxo-2'-Deoxyguanosine Derivatives
Inventors: 김용호, 김승훈, 강혜린, 조하늘, 용혜임, 김완훈
Pharmaceutical Composition for Prevention or Treatment of Pruritus Comprising TRPV1 Antagonist
Inventors: 김승훈, 신지윤, 김윤연, 용혜임, 구연수
Pharmaceutical Composition for Prevention or Treatment of Dry Eye Disease Comprising TRPV1 Antagonist
Inventors: 김승훈, 신지윤, 김윤연, 구영아, 최가은
Hypothalamus-Pituitary Biochip and Manufacturing Method Thereof
Inventors: -
Key Research Papers
RudaCure's key research achievements published in domestic and international SCI-indexed journals.
Comparison of Corneal Epithelial Wound Healing between Topical RCI001, Solcoseryl, and Polydeoxyribonucleotide in the Murine Ocular Alkali Burn Model
Kim SH et al.
Investigating the Anti-Inflammatory Effects of RCI001 for Treating Ocular Surface Diseases: Insight Into the Mechanism of Action
Kim SH et al.
Comparison of Therapeutic Effects between Topical 8-oxo-2'-deoxyguanosine and Corticosteroid in Ocular Alkali Burn Model
Kim SH et al.
Ocular Distribution and Pharmacokinetics of 8-Oxo-2'-Deoxyguanosine: A Novel Therapeutic Candidate of Ocular Surface Diseases
Kim SH et al.
Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker
Kim SH et al.
Improved Accuracy of Intraocular Lens Power Calculation by Preoperative Management of Dry Eye Disease
Kim SH et al.